HB3963ham001 93RD GENERAL ASSEMBLY

Human Services Committee

Adopted in House Comm. on Mar 04, 2004

09300HB3963ham001 LRB093 14875 MKM 48151 a

AMENDMENT TO HOUSE BILL 3963

AMENDMENT NO. ______. Amend House Bill 3963 on page 1, by replacing lines 5 and 6 with the following: "Clinical Research Act is amended by changing Sections 5 and 10 as follows:

(30 ILCS 785/5)

Sec. 5. Definitions. In this Act:

"Grantee" means any qualified public, private, or not-for-profit agency or individual, including, but not limited to, a college, university, hospital, laboratory, research institution, local health department, voluntary health agency, health maintenance organization, corporation, student, fellow, or entrepreneur, conducting clinical research using State funds. A grantee may also be a corporation that is headquartered in Illinois and that conducts research using State funds.

"Minority group" means a group that is a readily identifiable subset of the U.S. population that is distinguished by racial, ethnic, or cultural heritage. The following racial and ethnic categories shall be used as guidelines:

(1) "American Indian or Alaskan Native" means a person having origins in any of the original native peoples of North America and who maintains a cultural identification through tribal affiliation or community recognition.

(2) "Asian or Pacific Islander" means a person having origins in any of the original peoples of the Far East, Southeast Asia, the Indian subcontinent, or the Pacific Islands, including, but not limited to, China, India, Japan, Korea, the Philippine Islands, and Samoa.

(3) "Black" means someone not of Hispanic origin having origins in any of the black racial groups of Africa.

(4) "Hispanic" means a person of Mexican, Puerto Rican, Cuban, Central or South American, or other Spanish culture or origin, regardless of race. is defined as in the 2000 National Institutes of Health guidelines.

"Project of clinical research" includes a clinical trial.

(Source: P.A. 93-514, eff. 1-1-04.)"; and

on page 1, by replacing lines 20 and 21 with the following:

"(4) Comply with the National Institutes of Health Guidelines on the Inclusion of Women and Minorities in Clinical Research.".